American Association for the Advancement of Science, Science Translational Medicine, 334(8), 2016
DOI: 10.1126/scitranslmed.aaf0685
Full text: Unavailable
Cancer vaccine development has been vigorously pursued for 40 years. Immunity to tumor antigens can be elicited by most vaccines tested, but their clinical efficacy remains modest. We argue that a concerted international effort is necessary to understand the human antitumor immune response and achieve clinically effective cancer vaccines. Aci Transl Med 2016 Apr 13; 8(334):334ps9